Recent Updates
- Germany: Unfilled Orders, Manufacturing Orders Backlog (Dec)
- Japan: Trends in National Market for Condominiums (Jan)
- China: Retail Price Index (Jan)
- Singapore: Fixed Asset Investments (Q4)
- Australia: Overseas Arrivals and Departures (Dec)
- Korea: Import & Export Price Indexes (Jan)
- Turkey: House Price Index (Dec)
- UK: Rightmove HPI (Feb), LSL/Acadata HPI (Jan)
- more updates...
Economy in Brief
Import Prices Continue Their Decline; Both Oil and Nonoil Prices Move Lower
Import prices fell a greater-than-expected 0.5% during January (-1.7% year-on-year)...
Empire State Manufacturing Activity Improves Modestly
The Empire State Manufacturing Index of General Business Conditions rose to 8.8 during February...
EMU-16 Trade Flows and Balance
EMU-wide exports ticked lower in December as imports were flat...
U.S. Retail Sales Exhibit Extensive Weakness
Total retail sales declined 1.2% (+2.3% y/y) during December...
U.S. Producer Prices Decline; Core PPI Rises
The headline Final Demand Producer Price Index edged down 0.1% for the second consecutive month in January (+2.0% y/y)...
Robert Brusca
Haver Analytics is pleased to bring Robert A. Brusca's comments on the state of the global economy to its clients.
Robert A. Brusca is Chief Economist of Fact and Opinion Economics, a consulting firm he founded in Manhattan. He has been an economist on Wall Street for over 25 years. He has visited central banking and large institutional clients in over 30 countries in his career as an economist. Mr. Brusca was a Divisional Research Chief at the Federal Reserve Bank of NY (Chief of the International Financial markets Division), a Fed Watcher at Irving Trust and Chief Economist at Nikko Securities International. He is widely quoted and appears in various media.
Mr. Brusca holds an MA and Ph.D. in economics from Michigan State University and a BA in Economics from the University of Michigan. His research pursues his strong interests in non aligned policy economics as well as international economics. FAO Economics’ research targets investors to assist them in making better investment decisions in stocks, bonds and in a variety of international assets. The company does not manage money and has no conflicts in giving economic advice.